4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
A detailed review of FDA Adverse Event Reporting System (FAERS) data for generic sildenafil 20-100 mg, covering the most reported safety signals, serious adverse events, and what the post-market record means for prescribers and patients.
A comprehensive regulatory guide to generic sildenafil covering FDA approval history, EMA authorization, global OTC reclassification, label requirements, and post-market safety surveillance data.
A clinical overview of generic sildenafil's regulatory history, current FDA-approved formulations, pipeline developments, and next-generation delivery systems for erectile dysfunction and pulmonary arterial hypertension.
How the FDA and EMA each regulate generic sildenafil, from bioequivalence standards and labeling differences to post-market surveillance frameworks. Evidence-based comparison for clinicians and patients.